Doesn't seem at all reasonable that any person or institution would short a pre-revenue clinical stage biotech with three separate, promising drug platforms, ahead of near term clinical result news that is widely expected to be positive.
I mean, the total possible reward is 75 cents per share, with a reasonable worst-case possible exposure of over $5 a share. Doesn't make sense that anyone with brains would actually be short.
However... there could be entities that are trying to force a lower entry price for a large player, OR, agents of other pharma companies or agents of truly toxic financing outfits that would stand to gain from suppressing IPIX share price. Those make more sense to me than simply someone being dangeriously short.
And I will tell you... that several years ago there was one such institution that was wanting to provide then CTIX with truly toxic financing, and a representative of that institution made up an alias and was active on this very forum attempting to talk down share price ahead of a pending CTIX financing deal with some third party. I know this... because I had a hand in exposing the individual, complete with an IP record of a domain name in NYC owned by that shady financial firm. Dead to rights... the negative activity by that alias was originating from a financial firm's registered, named internet domain. After the person had been convincingly outed, he disappeared. This is a true story. There ARE bad people who illegally attempt to succeed at the expense of others.
DOTB
